Literature DB >> 19120894

Growth inhibitory action of cranberry on Helicobacter pylori.

Masashi Matsushima1, Takayoshi Suzuki, Aya Masui, Kouichi Kasai, Tomoko Kouchi, Atsushi Takagi, Takayuki Shirai, Tetsuya Mine.   

Abstract

BACKGROUND AND AIM: Cranberry is a fruit that originated in North America, and it has been used by Native Americans for bacterial infections. Recent studies have revealed it to be effective for preventing refractory urinary infections, while also suggesting that it plays a possible role in the eradication of Helicobacter pylori (H. pylori).
METHODS: The H. pylori strains used in the present study were NCTC11637 and 11638. Sugar and organic acid-rich, and polyphenol-rich fractions were obtained from cranberry juice concentrate by Amberlite XAD7HP-column chromatography. The H. pylori growth inhibition was estimated by OD(660) and titration in liquid culture, and by an agar dilution plate method. The shapes of the bacteria were analyzed by scanning electron microscopy.
RESULTS: Cranberry extract suppressed bacterial proliferation in a dose-dependent manner. In the comparison with other juices, polyphenol-rich fruits (cranberries, blueberries, and red grapes) showed similar growth inhibitory activity, whereas polyphenol-poor fruits (oranges, pineapples, apples, and white grapes) did not show any activity. The polyphenol-rich fraction of cranberry maintained the H. pylori-growth inhibitory activity. More bacteria in a coccoid form were observed after culture with cranberry.
CONCLUSION: Cranberry extract inhibited H. pylori proliferation and it is suggested that polyphenols are responsible for this action. The morphological analysis suggested that cranberry induces H. pylori to develop a coccoid form, thereby inhibiting its growth bacteriostatically. Further basic studies to clarify these mechanisms in combination with in vivo studies are needed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19120894     DOI: 10.1111/j.1440-1746.2008.05409.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  10 in total

Review 1.  Non-pharmacological treatment of Helicobacter pylori.

Authors:  Haim Shmuely; Noam Domniz; Jacob Yahav
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

Review 2.  Natural products and food components with anti-Helicobacter pylori activities.

Authors:  Hiroaki Takeuchi; Vu Thu Trang; Norihito Morimoto; Yoshie Nishida; Yoshihisa Matsumura; Tetsuro Sugiura
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

3.  Enteric-coated, highly standardized cranberry extract reduces risk of UTIs and urinary symptoms during radiotherapy for prostate carcinoma.

Authors:  Alberto Bonetta; Francesco Di Pierro
Journal:  Cancer Manag Res       Date:  2012-08-24       Impact factor: 3.989

4.  Perturbation of host cell cytoskeleton by cranberry proanthocyanidins and their effect on enteric infections.

Authors:  Kevin Harmidy; Nathalie Tufenkji; Samantha Gruenheid
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

5.  Cyanidin 3-O-glucoside reduces Helicobacter pylori VacA-induced cell death of gastric KATO III cells through inhibition of the SecA pathway.

Authors:  Sa-Hyun Kim; Hyunjun Woo; Min Park; Ki-Jong Rhee; Cheol Moon; Dongsup Lee; Woo Duck Seo; Jong Bae Kim
Journal:  Int J Med Sci       Date:  2014-05-14       Impact factor: 3.738

6.  Cranberry proanthocyanidins have anti-biofilm properties against Pseudomonas aeruginosa.

Authors:  Robert K Ulrey; Stephanie M Barksdale; Weidong Zhou; Monique L van Hoek
Journal:  BMC Complement Altern Med       Date:  2014-12-16       Impact factor: 3.659

7.  Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma.

Authors:  Alberto Bonetta; Giandomenico Roviello; Daniele Generali; Laura Zanotti; Maria Rosa Cappelletti; Chiara Pacifico; Francesco Di Pierro
Journal:  Res Rep Urol       Date:  2017-04-26

Review 8.  Current knowledge on alleviating Helicobacter pylori infections through the use of some commonly known natural products: bench to bedside.

Authors:  Malliga Raman Murali; Sangeetha Vasudevaraj Naveen; Chang Gue Son; Hanumantha Rao Balaji Raghavendran
Journal:  Integr Med Res       Date:  2014-04-24

Review 9.  Elicitation of Stress-Induced Phenolic Metabolites for Antimicrobial Applications against Foodborne Human Bacterial Pathogens.

Authors:  Ashish Christopher; Dipayan Sarkar; Kalidas Shetty
Journal:  Antibiotics (Basel)       Date:  2021-01-23

10.  Identification of Potential Drug Targets in Helicobacter pylori Using In Silico Subtractive Proteomics Approaches and Their Possible Inhibition through Drug Repurposing.

Authors:  Kareem A Ibrahim; Omneya M Helmy; Mona T Kashef; Tharwat R Elkhamissy; Mohammed A Ramadan
Journal:  Pathogens       Date:  2020-09-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.